| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Luis Bujanda | Q42426407 |
| Daniel D. Billadeau | Q88366174 | ||
| P2093 | author name string | Marta Herreros-Villanueva | |
| Jin-San Zhang | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Identification and characterization of ovarian cancer-initiating cells from primary human tumors | Q24644329 | ||
| Efficient tumour formation by single human melanoma cells | Q24648938 | ||
| Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells | Q24657020 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells | Q26827732 | ||
| Heterogeneity and targeting of pancreatic cancer stem cells | Q26851734 | ||
| Pancreatic cancer stem cells: emerging target for designing novel therapy | Q26863365 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Q27860831 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 | ||
| Identification of a cancer stem cell in human brain tumors | Q28131688 | ||
| The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells | Q28176663 | ||
| Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells | Q28176681 | ||
| ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma | Q28251362 | ||
| Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer | Q28274188 | ||
| Identification of pancreatic cancer stem cells | Q28286997 | ||
| Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice | Q28487437 | ||
| Multipotent cell lineages in early mouse development depend on SOX2 function | Q28513175 | ||
| Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells | Q28533295 | ||
| Reversing the intractable nature of pancreatic cancer by selectively targeting ALDH-high, therapy-resistant cancer cells | Q28534611 | ||
| Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells | Q28590205 | ||
| The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells | Q28593119 | ||
| Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts | Q29614794 | ||
| An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors | Q29615393 | ||
| Identification of bronchioalveolar stem cells in normal lung and lung cancer | Q29619267 | ||
| Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma | Q29620604 | ||
| SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas | Q30491937 | ||
| ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma | Q33939548 | ||
| DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer | Q34371518 | ||
| Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells | Q34399678 | ||
| Cancer stem cells: an old idea--a paradigm shift | Q34495973 | ||
| Tracing the derivation of embryonic stem cells from the inner cell mass by single-cell RNA-Seq analysis | Q34619418 | ||
| Human pancreatic cancer contains a side population expressing cancer stem cell-associated and prognostic genes | Q34998939 | ||
| Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells | Q35034700 | ||
| Differentiation of embryonic stem cells is induced by GATA factors | Q35777699 | ||
| Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells | Q35835273 | ||
| Genetic and epigenetic regulators of pluripotency | Q36744480 | ||
| Epigenetic signatures of stem-cell identity. | Q36761192 | ||
| Apoptotic pathways in pancreatic ductal adenocarcinoma | Q36835642 | ||
| The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer | Q36907124 | ||
| Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu | Q36922504 | ||
| Reprogramming of human primary somatic cells by OCT4 and chemical compounds | Q37267824 | ||
| Regulation of pluripotency and reprogramming by transcription factors | Q37280208 | ||
| HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. | Q37416242 | ||
| Extrinsic regulation of pluripotent stem cells | Q37763846 | ||
| Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives. | Q38010413 | ||
| Biology and clinical applications of pancreatic cancer stem cells | Q38102108 | ||
| COUP-TFII in pancreatic adenocarcinoma: clinical implication for patient survival and tumor progression | Q39079666 | ||
| Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells | Q39122871 | ||
| CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer | Q39265977 | ||
| Pancreatic cancer cells surviving gemcitabine treatment express markers of stem cell differentiation and epithelial-mesenchymal transition | Q39268201 | ||
| Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract | Q39547622 | ||
| CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. | Q39825558 | ||
| Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression | Q39893366 | ||
| DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer | Q41906889 | ||
| SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells | Q42092920 | ||
| uPAR-controlled oncolytic adenoviruses eliminate cancer stem cells in human pancreatic tumors | Q42261158 | ||
| Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplasti | Q42492435 | ||
| Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. | Q42971176 | ||
| Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. | Q43154857 | ||
| Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro | Q43833442 | ||
| Stem cell self-renewal controlled by chromatin remodeling factors. | Q52662925 | ||
| Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. | Q53279352 | ||
| Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors | Q63384348 | ||
| Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens | Q80099843 | ||
| Sox2 expression in breast tumours and activation in breast cancer stem cells | Q84709308 | ||
| c-Met is a marker of pancreatic cancer stem cells and therapeutic target | Q84816959 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 2247-2254 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Embryonic stem cell factors and pancreatic cancer | |
| P478 | volume | 20 |
| Q38737118 | A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells |
| Q95841376 | An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness |
| Q28543279 | Autoregulation and heterogeneity in expression of human Cripto-1 |
| Q53687842 | Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. |
| Q36156256 | Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine |
| Q38699708 | Cancer stem cell markers in patterning differentiation and in prognosis of oral squamous cell carcinoma. |
| Q37598500 | Cancer stem-like cells can be induced through dedifferentiation under hypoxic conditions in glioma, hepatoma and lung cancer |
| Q35742348 | Combination of carbon ion beam and gemcitabine causes irreparable DNA damage and death of radioresistant pancreatic cancer stem-like cells in vitro and in vivo |
| Q30842293 | Encapsulated cells expressing a chemotherapeutic activating enzyme allow the targeting of subtoxic chemotherapy and are safe and efficacious: data from two clinical trials in pancreatic cancer |
| Q33735050 | Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. |
| Q38555813 | Gene of the month: NANOG. |
| Q90590071 | Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis |
| Q38799986 | Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer |
| Q36016816 | Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells. |
| Q36547939 | Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer |
| Q59805940 | Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling |
| Q97884635 | Immunohistochemical analysis of SOX2 expression in small-cell neuroendocrine carcinoma of the endometrium |
| Q64279635 | Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog |
| Q42365079 | Leptin signaling and cancer chemoresistance: Perspectives |
| Q30396675 | Leptin-Notch signaling axis is involved in pancreatic cancer progression |
| Q35585395 | Long noncoding RNA MALAT-1 enhances stem cell-like phenotypes in pancreatic cancer cells |
| Q91912161 | Methylation profile of bovine Oct4 gene coding region in relation to three germ layers |
| Q38991690 | MiR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4. |
| Q38874409 | NANOG overexpression and its correlation with stem cell and differentiation markers in meningiomas of different WHO grades. |
| Q38256341 | NANOG: a promising target for digestive malignant tumors |
| Q26750944 | Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have |
| Q37174814 | Oncogenic NanogP8 expression regulates cell proliferation and migration through the Akt/mTOR signaling pathway in human gastric cancer - SGC-7901cell line |
| Q92460931 | Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting |
| Q36082969 | Polyphenols from marine brown algae target radiotherapy-coordinated EMT and stemness-maintenance in residual pancreatic cancer |
| Q90324677 | Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker |
| Q90054058 | ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer |
| Q28469365 | Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment |
| Q92374216 | Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells |
| Q90043990 | SOX2 mediates cisplatin resistance in small-cell lung cancer with downregulated expression of hsa-miR-340-5p |
| Q94463957 | Silencing of microRNA-135b inhibits invasion, migration, and stemness of CD24+CD44+ pancreatic cancer stem cells through JADE-1-dependent AKT/mTOR pathway |
| Q26744774 | Stem cells to replace or regenerate the diabetic pancreas: Huge potential & existing hurdles |
| Q57094352 | The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer |
| Q26992103 | Very small embryonic-like stem cells are involved in pancreatic regeneration and their dysfunction with age may lead to diabetes and cancer |
| Q38708727 | eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth |
Search more.